A Framework for Improving the Generalizability of Drug–Target Affinity Prediction Models
Journal of Computational Biology, 2023Statistical models that accurately predict the binding affinity of an input ligand-protein pair can greatly accelerate drug discovery. Such models are trained on available ligand-protein interaction data sets, which may contain biases that lead the predictor models to learn data set-specific, spurious patterns instead of generalizable relationships ...
Riza Özçelik +5 more
openaire +2 more sources
A Mutual Attention Model for Drug Target Binding Affinity Prediction
IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2022Vrious machine learning approaches have been developed for drug-target interaction (DTI) prediction. One class of these approaches, DTBA, is interested in Drug-Target Binding Affinity strength, rather than focusing merely on the presence or absence of interaction. Several machine learning methods have been developed for this purpose.
openaire +2 more sources
Multimodal contrastive representation learning for drug-target binding affinity prediction
Methods, 2023In the biomedical field, the efficacy of most drugs is demonstrated by their interactions with targets, meanwhile, accurate prediction of the strength of drug-target binding is extremely important for drug development efforts. Traditional bioassay-based drug-target binding affinity (DTA) prediction methods cannot meet the needs of drug R&D in the era ...
Linlin, Zhang +4 more
openaire +2 more sources
Similarity-Adaptive interaction routing for Drug–Target affinity prediction
Journal of Biomedical InformaticsDrug-target affinity (DTA) prediction is an important task in computer-aided drug discovery. Existing methods usually use a fixed drug-protein interaction strategy. This design is hard to adapt to heterogeneous samples. It is also limited in cold-start and low-similarity scenarios. This study proposes SIGMA-DTA, a similarity-guided adaptive interaction
Ziyou Zhou +3 more
openaire +2 more sources
Contrastive Meta-Learning for Drug-Target Binding Affinity Prediction
2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2022Mei Li +4 more
openaire +1 more source
Drug-target Affinity Prediction by Molecule Secondary Structure Representation Network
Current Medicinal ChemistryIntroduction: Identification of drug-target interactions (DTI) is a crucial step in drug development with high specificity and low toxicity. To accelerate the process, computer-aided DTI prediction algorithms have been used to screen compounds or targets rapidly. Furthermore, DTI prediction can be used to identify potential targets for existing drugs,
Yuewei, Tang +3 more
openaire +2 more sources
Classification prediction of drug target binding affinity based on the MolrProtTrans model
Analytical BiochemistryPredicting drug-target interactions is essential for virtual drug screening. While many models predict the binding affinity between small molecules and proteins, they often overemphasize molecular features while overlooking important protein characteristics, leading to biased predictions.
Yicun Lin +3 more
openaire +2 more sources
GFLearn: Generalized Feature Learning for Drug-Target Binding Affinity Prediction
IEEE Journal of Biomedical and Health InformaticsPredicting drug-target binding affinity is critical for drug discovery, as it helps identify promising drug candidates and predict their effectiveness. Recent advancements in deep learning have made significant progress in tackling this task. However, existing methods heavily rely on training data, and their performance is often limited when predicting
Zibo Huang, Xinrui Weng, Le Ou-Yang
openaire +2 more sources
Drug-Target Affinity Prediction Based on Improved GraphDTA
2023 5th International Conference on Robotics and Computer Vision (ICRCV), 2023Zi Ye +3 more
openaire +1 more source
LLMDTA: Improving Cold-Start Prediction in Drug-Target Affinity with Biological LLM
IEEE Transactions on Computational Biology and BioinformaticsDrug-target affinity (DTA) prediction plays a crucial role in accelerating the drug development process. Although deep learning-based models achieve strong performance in benchmark datasets, their predictive accuracy declines sharply in cold-start scenarios, i.e., when encountering drugs or proteins absent from the training set.
Wuguo Tang +2 more
openaire +2 more sources

